Despesa De Juros Sobre A Dívida Alterar Data
argenx SE USD 1000K 0 2026-09
AstraZeneca USD 371M 31M 2026-09
Biogen USD 72.6M 12.6M 2025-06
Genmab DKK 139M 129M 2026-06
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
GRIFOLS EUR 141.43M 61.28M 2025-06
Hikma Pharmaceutical USD 67M 47M 2025-12
Incyte USD 605K 23K 2026-09
Merck EUR 137M 33M 2026-06
Neurocrine Biosciences USD 300K 2.6M 2026-09
Novartis USD 468M 6M 2026-09
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 222M 65M 2026-09
UCB EUR 49M 29M 2025-12
Vertex Pharmaceuticals USD 36M 32.7M 2026-09